Today The Boston Scientific Corporation announced that they have received CE Mark approval for the use of deep brain stimulation for the treatment of primary and secondary dystonia. Read the press release here.

Last week Dystonia Europe President Robert Scholten and Executive Director Monika Benson met with the Boston Scientific team outside of Paris to discuss their collaboration for dystonia. Boston Scientific is an American medical device company and their products and technologies are used to diagnose or treat medical conditions, including heart, digestive, pulmonary, vascular, urological, women’s health,…

Hear Alistair Newton sharing how he felt when he discovered the first symptoms of dystonia.  

On September 6 & 7 Dystonia Europe celebrated its 20th Anniversary with the Conference “Achievement & Hope” in Edinburgh Scotland. About 85 participants from all over Europe attended the 2-day-event. The program contained a variety of presentations such as for example DBS treatment, Physiotherapy, Genetics, Living Well with Dystonia and many more. Read more about…

We congratulate this year’s winner, Dr. Katja Lohmann, of the Institute of Neruogenetics at the university of Lübeck in Germany, for her paper entitled: “Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene” The Adjudication Panel of our Medical and Scientific Advisory Board assessed this paper to be the best of…